429
Views
82
CrossRef citations to date
0
Altmetric
Review

Use of nanoparticles for drug delivery in glioblastoma multiforme

Pages 363-372 | Published online: 09 Jan 2014

References

  • Jain KK. Future prospects for the cure of brain cancer. Technol. Cancer Res. Treat.5, 183–184 (2006).
  • Newton H. Advances in strategies to improve drug delivery to brain tumors. Expert Rev. Neurother.6, 1495–1509 (2006).
  • Jain KK. Nanotechnology-based drug delivery for cancer. Technol. Cancer Res. Treat.4, 311–314 (2005).
  • Jain KK. Nanobiotechnology: Applications, Markets and Companies. Jain PharmaBiotech Publications, Basel, Switzerland (2007).
  • Koo YE, Reddy GR, Bhojani M et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv. Drug Deliv. Rev.58, 1556–1577 (2006).
  • Koziara JM, Lockman PR, Allen DD, Mumper RJ. Paclitaxel nanoparticles for the potential treatment of brain tumors. J. Control. Release99, 259–269 (2004).
  • Jeong YI, Kim SH, Jung TY et al. Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J. Pharm. Sci.95, 2348–2360 (2006).
  • Xie J, Wang CH. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm. Res.23, 1817–1826 (2006).
  • Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev.47, 65–81 (2001).
  • Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J. Microencapsul.23, 582–592 (2006).
  • Petri B, Bootz A, Khalansky A et al. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J. Control. Release117, 51–58 (2007).
  • Steiniger SC, Kreuter J, Khalansky AS et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer109, 759–767 (2004).
  • Zhang Y, Sun C, Kohler N et al. Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomed. Microdevices6, 33–40 (2004).
  • Simberg D, Duza T, Park JH et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA104, 932–936 (2007).
  • Wu G, Barth RF, Yang W et al. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug. Chem.15, 185–194 (2004).
  • Yang W, Barth RF, Wu G et al. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin. Cancer Res.12, 3792–3802 (2006).
  • Abraham SA, Waterhouse DN, Mayer LD et al. The liposomal formulation of doxorubicin. Methods Enzymol.391, 71–97 (2005).
  • Madhankumar AB, Slagle-Webb B, Mintz A et al. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol. Cancer Ther.5, 3162–3169 (2006).
  • Mamot C, Drummond DC, Noble CO et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res.65, 1631–11638 (2005).
  • Lopez KA, Waziri AE, Canoll PD, Bruce JN. Convection-enhanced delivery in the treatment of malignant glioma. Neurol. Res.28, 542–548 (2006).
  • Saito R, Bringas JR, McKnight TR et al. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res.64, 2572–2579 (2004).
  • Krauze MT, Forsayeth J, Park JW, Bankiewicz KS. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res.23, 2493–2504 (2006).
  • Noble CO, Krauze MT, Drummond DC et al. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res.66, 2801–2806 (2006).
  • Jordan A, Scholz R, Maier-Hauff K et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol.78, 7–14 (2006).
  • Maier-Hauff K, Rothe R, Scholz R et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol.81, 53–60 (2007).
  • Plotkin M, Gneveckow U, Meier-Hauff K et al.18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int. J. Hyperthermia22, 319–325 (2006).
  • Reddy GR, Bhojani MS, McConville P et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res.12, 6677–6686 (2006).
  • Kopelman R, Philbert M, Koo YEL et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magnetism Magnetic Mater.293, 404–410 (2005).
  • Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res.66, 11878–11887 (2006).
  • Yu W, Pirollo KF, Rait A et al. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther.11, 1434–1440 (2004).
  • Reszka RC, Jacobs A, Voges J. Liposome-mediated suicide gene therapy in humans. Methods Enzymol.391, 200–208 (2005).
  • Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood105, 420–425 (2005).
  • Peters A, Veronesi B, Calderon-Garciduenas L et al. Translocation and potential neurological effects of fine and ultrafine particles: a critical update. Part. Fibre Toxicol.3, 13 (2006).
  • Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery57, 785–796 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.